focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIND.L Regulatory News (IND)

  • There is currently no data for IND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Indigovision Group

11 Jan 2012 11:30

RNS Number : 3762V
Scottish Equity Partners LLP
11 January 2012
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Scottish Equity Partners LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

SEP IV LP (through its wholly-owned subsidiary, Kuiper Limited)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Indigovision plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEROR

(e) Date position held:

11 January 2012

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of Indigovision plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

500,000

6.6

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

500,000

6.6

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

Dr Oliver Vellacott who is directly and indirectly interested in an aggregate of 1,725,949 ordinary shares of IndigoVision Group plc (representing approximately 22.9% of the issued ordinary shares in the capital of the company).

Dr Vellacott also holds options to subscribe for a total of 170,178 ordinary shares under various schemes put in place by IndigoVision Group plc.

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

11 January 2012

Contact name:

Andrew Buchan

Telephone number:

0141 273 4040

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEBBGDBRDBBGDB
Date   Source Headline
2nd May 201910:41 amRNSDirector/PDMR Shareholding
1st May 201912:00 pmRNSDirector/PDMR Shareholding
23rd Apr 20199:36 amRNSDirector/PDMR Shareholding
18th Apr 20195:19 pmRNS2018 Annual Report & Notice of AGM
29th Mar 20197:00 amRNSAppointment of Non-Executive Director
12th Mar 201911:45 amRNSDirector/PDMR Shareholding
11th Mar 20197:00 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSTrading Statement
21st Nov 20183:45 pmRNSGrant of awards under the Company's 2018 LTIP
24th Oct 201810:25 amRNSResult of General Meeting
5th Oct 20187:00 amRNSPosting of Circular & Notice of General Meeting
4th Oct 20185:38 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSHalf-year Report
15th Aug 20187:00 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSPDMR Shareholding
17th May 20182:49 pmRNSResult of AGM
17th May 20187:00 amRNSAGM Trading Update
25th Apr 20182:52 pmRNSDirector/PDMR Shareholding
24th Apr 20184:57 pmRNS2017 Annual Report
20th Mar 20183:57 pmRNSPDMR Shareholding
15th Mar 20183:01 pmRNSDirector Shareholding
12th Mar 20189:20 amRNSCancellation of Block Listing & TVR
9th Mar 20186:07 pmRNSHolding(s) in Company
9th Mar 20186:05 pmRNSHolding(s) in Company
8th Mar 20184:26 pmRNSHolding(s) in Company
7th Mar 20185:56 pmRNSHolding(s) in Company
5th Mar 20188:31 amRNSPDMR Shareholdings
1st Mar 20187:00 amRNSFinal Results
9th Jan 20187:00 amRNSAppointment of Chief Executive Officer
28th Dec 201712:55 pmRNSBlock listing Interim Review
30th Nov 20177:00 amRNSHolding(s) in Company
27th Nov 20175:00 pmRNSPDMR Shareholding
24th Nov 20172:08 pmRNSPDMR Shareholding
24th Nov 20172:07 pmRNSTransaction in Own Shares
24th Nov 20177:00 amRNSTrading update and Board changes
20th Oct 20172:51 pmRNSGrant of Options
16th Oct 20177:00 amRNSDirectorate Change
2nd Oct 20172:00 pmRNSPDMR Appointment
22nd Sep 20173:31 pmRNSDirectors Dealings
22nd Sep 20177:00 amRNSInterim Results
18th Aug 20171:30 pmRNSPDMR Shareholding
1st Aug 20177:00 amRNSBoard Change
21st Jun 20173:46 pmRNSHolding(s) in Company
20th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSTransaction in Own Shares
12th Jun 20177:00 amRNSTransaction in Own Shares
5th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSDirectorate Change
30th May 20177:00 amRNSDirectorate Change
23rd May 20177:00 amRNSShare Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.